The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease. Mokhles, M. M., Trifirò, G., Dieleman, J. P., Haag, M. D., Van Soest, E. M., Verhamme, K. M. C., Mazzaglia, G., Herings, R., De Luise, C., Ross, D., Brusselle, G., Colao, A., Haverkamp, W., Schade, R., Van Camp, G., Zanettini, R., & Sturkenboom, M. C. J. M. Pharmacological Research, 65(3):358-364 , DOI = 10.1016/j.phrs.2011.11.009, 2012.
The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease [link]Paper  bibtex   
@article{RN367,
   author = {Mokhles, M. M. and Trifirò, G. and Dieleman, J. P. and Haag, M. D. and Van Soest, E. M. and Verhamme, K. M. C. and Mazzaglia, G. and Herings, R. and De Luise, C. and Ross, D. and Brusselle, G. and Colao, A. and Haverkamp, W. and Schade, R. and Van Camp, G. and Zanettini, R. and Sturkenboom, M. C. J. M.},
   title = {The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease},
   journal = {Pharmacological Research},
   volume = {65},
   number = {3},
   pages = {358-364 , DOI = 10.1016/j.phrs.2011.11.009},
   url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-84857055235&doi=10.1016%2fj.phrs.2011.11.009&partnerID=40&md5=e404d73bea8a1885e08220b7907786c1},
   year = {2012},
   type = {Journal Article}
}

Downloads: 0